BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24332520)

  • 1. Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system.
    Schiodt M; Reibel J; Oturai P; Kofod T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):204-13. PubMed ID: 24332520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed.
    Fedele S; Bedogni G; Scoletta M; Favia G; Colella G; Agrillo A; Bettini G; Di Fede O; Oteri G; Fusco V; Gabriele M; Ottolenghi L; Valsecchi S; Porter S; Fung PP; Saia G; Campisi G; Bedogni A
    Br J Oral Maxillofac Surg; 2015 Jan; 53(1):13-7. PubMed ID: 25282593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
    Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S
    J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients.
    Ehrenstein V; Gammelager H; Schiødt M; Nørholt SE; Neumann-Jensen B; Folkmar TB; Pedersen L; Svaerke C; Sørensen HT; Ma H; Acquavella J
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):693-700. PubMed ID: 25974710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort.
    Yazdi PM; Schiodt M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):416-22. PubMed ID: 25697927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
    Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA
    Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study.
    Yamazaki T; Yamori M; Ishizaki T; Asai K; Goto K; Takahashi K; Nakayama T; Bessho K
    Int J Oral Maxillofac Surg; 2012 Nov; 41(11):1397-403. PubMed ID: 22840716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
    Bagan JV; Hens-Aumente E; Leopoldo-Rodado M; Poveda-Roda R; Bagan L
    Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of positron emission tomography in osteonecrosis of the jaws?
    Belcher R; Boyette J; Pierson T; Siegel E; Bartel TB; Aniasse E; Stack B
    J Oral Maxillofac Surg; 2014 Feb; 72(2):306-10. PubMed ID: 24075237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw and survival of patients with cancer: a nationwide cohort study in Denmark.
    Corraini P; Heide-Jørgensen U; Schiødt M; Nørholt SE; Acquavella J; Sørensen HT; Ehrenstein V
    Cancer Med; 2017 Oct; 6(10):2271-2277. PubMed ID: 28941210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
    Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
    J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws.
    Lee CY; Pien FD; Suzuki JB
    Implant Dent; 2011 Oct; 20(5):331-6. PubMed ID: 21881516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral health risk factors for bisphosphonate-associated jaw osteonecrosis.
    Tsao C; Darby I; Ebeling PR; Walsh K; O'Brien-Simpson N; Reynolds E; Borromeo G
    J Oral Maxillofac Surg; 2013 Aug; 71(8):1360-6. PubMed ID: 23582590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.